FinancialRecon

Joint Reconstruction Devices Market Size to Grow by USD 5.58 Bn | Increasing Prevalence of Orthopedic Diseases and Associated Risk Factors to Drive Growth | Technavio

NEW YORK, Oct. 22, 2021 /PRNewswire/ — The global joint reconstruction devices market is set to grow by USD 5.58 billion from 2021 to 2025, accelerating at a CAGR of 5% during the forecast period, according to Technavio. The report offers an up-to-date analysis of the growth variance and the Y-O-Y growth rate.

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. AMPLITUDE SAS, Arthrex Inc., B. Braun Melsungen AG, Conformis Inc., Corin Group Plc, DJO Global Inc., EVOLUTIS SAS, Integra LifeSciences Holdings Corp., and Zimmer Biomet Holdings Inc. are some of the major market participants. Although the increasing prevalence of orthopedic diseases and associated risk factors will offer immense growth opportunities, high implant prices coupled with decreasing reimbursement will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Joint Reconstruction Devices Market 2021-2025: Segmentation

Joint Reconstruction Devices Market is segmented as below:

  • Product
    • Knee Replacement
    • Trauma And Extremities
    • Hip Replacement
  • Geography
    • North America
    • Europe
    • Asia
    • ROW

For more information on the contribution of all the segments and regional growth,
Download a Free Sample Report Now

Joint Reconstruction Devices Market 2021-2025: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our joint reconstruction devices market report covers the following areas:

This study identifies technological advances and new product launches as the prime reasons driving the joint reconstruction devices market growth during the next few years.

Joint Reconstruction Devices Market 2021-2025: Vendor Analysis

We provide a detailed analysis of around 25 vendors operating in the Joint Reconstruction Devices Market. Backed with competitive intelligence and benchmarking, our research report on the Joint Reconstruction Devices Market is designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.

Subscribe to our “Lite Plan” billed annually at USD 3000 that enables you to download 3 reports/year and view 3 reports/month.

Joint Reconstruction Devices Market 2021-2025: Key Highlights

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will assist joint reconstruction devices market growth during the next five years
  • Estimation of the joint reconstruction devices market size and its contribution to the parent market
  • Predictions on upcoming trends and changes in consumer behavior
  • The growth of the joint reconstruction devices market
  • Analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of joint reconstruction devices market vendors

Related Reports:
Global Cementless Total Knee Arthroplasty Market
 – Global cementless total knee arthroplasty market is segmented by product (fixed-bearing and mobile-bearing) and geography (North America, Europe, Asia, and ROW).
Download Exclusive Free Sample Report

Global Bone Cement Market – Global bone cement market is segmented by product (antibiotic-loaded bone cement and non-antibiotic loaded bone cement) and geography (North America, Europe, Asia, and ROW).
Download Exclusive Free Sample Report

Joint Reconstruction Devices Market Scope
Report CoverageDetails
Page number120
Base year2020
Forecast period2021-2025
Growth momentum & CAGRAccelerate at a CAGR of almost 5%
Market growth 2021-2025USD 5.58 billion
Market structureFragmented
YoY growth (%)3.56
Regional analysisNorth America, Europe, Asia, and ROW
Performing market contributionNorth America at 50%
Key consumer countriesUS, Canada, Germany, UK, France, China, and Japan
Competitive landscapeLeading companies, competitive strategies, consumer engagement scope
Companies profiledAMPLITUDE SAS, Arthrex Inc., B. Braun Melsungen AG, Conformis Inc., Corin Group Plc, DJO Global Inc., EVOLUTIS SAS, Integra LifeSciences Holdings Corp., and Zimmer Biomet Holdings Inc.
Market DynamicsParent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period.
Customization purviewIf our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

SOURCE Technavio

For more insights on the potential growth variance, Read our Free Sample Report

Print Friendly, PDF & Email

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button